Espada, Luis C.

HRN: 22-75-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2023
CEFTRIAXONE 1G (VIAL)
03/19/2023
03/26/2023
IV
2 Grams
Q24h
CAP-HR
Waiting Final Action 
03/19/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/19/2023
03/26/2023
IV
600 Mg
Q8h
CAP-HR
Waiting Final Action 
03/19/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/19/2023
03/19/2023
IV
4.5 Grams
Ld
Cap Mr
Waiting Final Action 
03/19/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/19/2023
03/25/2023
IV
2.25 Grams
Q 6 Hrs
Cap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: